Cases
Search
Statistics
Estimate
SEARCH
Show Filters
Decision Date
2020
(1)
2018
(2)
2017
(3)
2015
(1)
Decision
Transfer
(7)
Complainant
“Dr. Martens” International Trading GmbH
(1)
“Dr. Maertens” Marketing GmbH
(1)
STYLIGHT GMBH
(1)
Boehringer Ingelheim Pharma gmbh & co. Kg
(1)
Boehringer Ingelheim Pharma GmbH & Co.KG
(1)
Bayer AG
(1)
BOEHRINGER Ingelheim Pharma GmbH & Co. KG
(1)
Allianz SE
(1)
Respondent
ZhangXin
(2)
huang cheng
(1)
Zheng Luo
(1)
Wang Lian Feng
(1)
Taminato Kiyoko
(1)
Pan Jing
(1)
Panelist
Sok Ling Moi
(1)
Kimberley Chen Nobles
(1)
Jonathan Agmon
(1)
Francine Tan
(1)
Douglas Clark
(1)
Deanna Wong Wai Man
(1)
Carol Anne Been
(1)
Complainant Country
Germany
(7)
Complainant Representative
Nameshield
(3)
BPM Legal
(2)
Tobias Unterguggenberger
(1)
Beetz & Partner
(1)
Respondent Country
China
(7)
Respondent Reply
Yes
(1)
No
(6)
RDNH Status
No
(7)
Case Language
English
(7)
Case Particular
D
(7)
Number Of Domains
1
(5)
2
(2)
Domain Extension
online
(7)
site
(1)
club
(1)
Domain Extension Type
newgTLD
(7)
Domain Length
5
(1)
7
(2)
8
(1)
9
(2)
14
(1)
Includes Hyphen
No
(7)
Includes Number
No
(7)
Includes Letter
Yes
(7)
Domain Registrar
Alibaba Cloud Computing Ltd. d/b/a HiChina (www.net.cn)
(4)
GoDaddy.com, LLC
(1)
EJEE Group Holdings Limited
(1)
Chengdu West Dimension Digital Technology Co., Ltd.
(1)
7
cases found.
Case Language: English
Complainant Country: Germany
Domain Extension: online
Includes Letter: Yes
Respondent Country: China
Reset Search
boehringerplus.online
Transfer
WIPO D2019-3109
(Decision Date: March 20, 2020)
stylight.online
Transfer
WIPO D2018-1393
(Decision Date: Aug. 14, 2018)
giotrif.online, giotrif.site
Transfer
WIPO D2018-0562
(Decision Date: May 14, 2018)
allianz.online
Transfer
WIPO D2017-1846
(Decision Date: Nov. 11, 2017)
drmartens.online
Transfer
WIPO D2017-1279
(Decision Date: Aug. 25, 2017)
combivent.club, combivent.online
Transfer
WIPO D2017-0660
(Decision Date: June 18, 2017)
bayer.online
Transfer
WIPO D2015-1932
(Decision Date: Dec. 19, 2015)
Stay updated! Get new cases and decisions by daily email.
leave this field blank to prove your humanity
Subscribe
Scroll